[go: up one dir, main page]

MX168415B - Procedimiento para la preparacion de derivados de silibinina - Google Patents

Procedimiento para la preparacion de derivados de silibinina

Info

Publication number
MX168415B
MX168415B MX009022A MX902285A MX168415B MX 168415 B MX168415 B MX 168415B MX 009022 A MX009022 A MX 009022A MX 902285 A MX902285 A MX 902285A MX 168415 B MX168415 B MX 168415B
Authority
MX
Mexico
Prior art keywords
independently
ethyl acetate
weight
ethanol
alkali metal
Prior art date
Application number
MX009022A
Other languages
English (en)
Spanish (es)
Inventor
Hartwig Soicke
Karlheinz Schmidt
Reinhard Braatz
Klaus Gorler
Gunter Halbach
Original Assignee
Madaus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus Ag filed Critical Madaus Ag
Publication of MX168415B publication Critical patent/MX168415B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
MX009022A 1984-11-22 1985-11-22 Procedimiento para la preparacion de derivados de silibinina MX168415B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (1)

Publication Number Publication Date
MX168415B true MX168415B (es) 1993-05-24

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
MX009022A MX168415B (es) 1984-11-22 1985-11-22 Procedimiento para la preparacion de derivados de silibinina

Country Status (29)

Country Link
JP (1) JPS61143377A (sv)
KR (1) KR870001020B1 (sv)
AR (1) AR240931A1 (sv)
AT (1) AT393268B (sv)
BE (1) BE903693A (sv)
CA (1) CA1337124C (sv)
CH (1) CH659473A5 (sv)
CS (1) CS273610B2 (sv)
DD (1) DD259191A1 (sv)
DE (1) DE3442639A1 (sv)
DK (1) DK164865C (sv)
EG (1) EG19424A (sv)
ES (1) ES8609311A1 (sv)
FI (1) FI84064C (sv)
FR (1) FR2573427B1 (sv)
GB (1) GB2167414B (sv)
HU (1) HU195503B (sv)
IE (1) IE58791B1 (sv)
IT (1) IT1190426B (sv)
LU (1) LU86163A1 (sv)
MX (1) MX168415B (sv)
NL (1) NL192387C (sv)
NO (1) NO160205C (sv)
PL (1) PL146890B1 (sv)
PT (1) PT81532B (sv)
SE (1) SE465676B (sv)
SU (1) SU1436875A3 (sv)
YU (1) YU43689B (sv)
ZA (1) ZA858951B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
DK1856085T3 (en) * 2005-03-11 2015-10-05 Howard Florey Inst Pty Ltd FLAVONOID COMPOUNDS AND APPLICATIONS THEREOF
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
WO2009062737A1 (en) * 2007-11-15 2009-05-22 Madaus Gmbh Silibinin component for the treatment of hepatitis
AU2010247716B2 (en) * 2009-05-14 2015-11-05 Madaus Gmbh Amorphous silibinin for the treatment of viral hepatitis
US20150174213A1 (en) 2012-07-05 2015-06-25 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and ursolic acid
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
GB8528226D0 (en) 1985-12-18
JPS61143377A (ja) 1986-07-01
FI854535A0 (fi) 1985-11-18
FR2573427A1 (fr) 1986-05-23
ES549116A0 (es) 1986-09-01
HU195503B (en) 1988-05-30
BE903693A (fr) 1986-05-22
YU43689B (en) 1989-10-31
NO160205B (no) 1988-12-12
SE8505487D0 (sv) 1985-11-20
CA1337124C (en) 1995-09-26
DK164865C (da) 1993-01-18
CS837885A2 (en) 1990-08-14
FI84064C (sv) 1991-10-10
DE3442639C2 (sv) 1989-08-10
AR240931A1 (es) 1991-03-27
FR2573427B1 (fr) 1989-03-10
HUT40114A (en) 1986-11-28
YU178685A (en) 1988-02-29
DK164865B (da) 1992-08-31
FI84064B (fi) 1991-06-28
ES8609311A1 (es) 1986-09-01
AR240931A2 (es) 1991-03-27
LU86163A1 (de) 1986-03-24
GB2167414A (en) 1986-05-29
EG19424A (en) 1995-02-28
DE3442639A1 (de) 1986-05-22
DK537785D0 (da) 1985-11-21
JPH0432073B2 (sv) 1992-05-28
IT1190426B (it) 1988-02-16
SU1436875A3 (ru) 1988-11-07
NL8503171A (nl) 1986-06-16
KR860004056A (ko) 1986-06-16
ZA858951B (en) 1986-08-27
DK537785A (da) 1986-05-23
NL192387B (nl) 1997-03-03
PT81532A (de) 1985-12-01
CS273610B2 (en) 1991-03-12
CH659473A5 (de) 1987-01-30
SE8505487L (sv) 1986-05-23
AT393268B (de) 1991-09-25
KR870001020B1 (ko) 1987-05-23
PT81532B (pt) 1987-11-11
ATA337185A (de) 1991-02-15
IE58791B1 (en) 1993-11-17
NO854655L (no) 1986-05-23
IT8522932A0 (it) 1985-11-21
NL192387C (nl) 1997-07-04
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
DD259191A1 (de) 1988-08-17
PL256374A1 (en) 1986-12-02
GB2167414B (en) 1989-01-11
FI854535A (fi) 1986-05-23
NO160205C (no) 1989-03-22
IE852808L (en) 1986-05-22

Similar Documents

Publication Publication Date Title
MX168415B (es) Procedimiento para la preparacion de derivados de silibinina
Elvidge et al. 461. Unsaturated lactones and related substances. Part IV. Lactonic products derived from muconic acid
US2656366A (en) Water-soluble esters of cortisone and related compounds
US3580936A (en) 5beta-taurocholenic acids and 5beta-taurocholadienic acids
Walborsky et al. Reaction of Ezo-norbornylene Oxide with Hydrogen Bromide
Cristol et al. Bridged Polycyclic Compounds. VII. The Bromination of Quadricyclo [2, 2, 1, 02, 6, 03, 5] heptane-2, 3-dicarboxylic Acid1, 2
ES2035102T3 (es) Compuestos que contienen hierro biodisponible, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
US2379381A (en) Composition of matter
Behrman The bacterial oxidation of nicotinic acid: N-Formylmaleamic and N-formylfumaramic acids
Fujimoto et al. A Synthesis of Progesterone Labeled in Position 41
GB1203538A (en) Cubane derivatives
US2128199A (en) Antirachitically active product
ES410060A1 (es) Un procedimiento de desdoblamiento de dl-aletrolona.
JPS53108933A (en) Production of amidinoformic acid derivative
GB722594A (en) Improvements in the manufacture of cellulose esters
PH13267A (en) D*honoandrostant-117oc-carboxylic acid derivatives
Wu et al. Oleanolic acid from cranberries
NAKATA et al. Diterpenoids. XXXIV. Stereochemistry on the Rearranged Compound (Benzilic Acid Rearrangement) of Methyl 6, 7-Dioxo-5α, 10α-podocarpa-8, 11, 13-trien-15-oate
US2621181A (en) Steroid adducts
GB1421527A (en) Dicarboxylic acid
GB512583A (en) Improvements in preparation of salts of hexamethylenetetramine
GB513818A (en) Improvements in and relating to the manufacture of compounds of p-tolylmethylcarbinol
HU229607B1 (en) Anhydride stabilization
Bourne et al. 251. Studies of trifluoroacetic acid. Part XIV. Reaction of acyl trifluoroacetates with 1: 6-di-O-benzoyl-2: 4–3: 5-di-O-methylene-D-glucitol
GB890749A (en) Esters of testosterone and 19-nortestosterone, and method for the production thereof